Vaccination Site and Risk of Local Reactions in Children 1 Through 6 Years of Age

Group Health Research Institute, Seattle, Washington
PEDIATRICS (Impact Factor: 5.47). 01/2013; 131(2). DOI: 10.1542/peds.2012-2617
Source: PubMed


Our objective was to assess whether the occurrence of medically attended local reactions to intramuscularly administered vaccines varies by injection site (arm versus thigh) in children 1 to 6 years of age.

This is a retrospective cohort study of children in the Vaccine Safety Datalink population from 2002 to 2009. Site of injection and the outcome of medically attended local reactions were identified from administrative data.

The study cohort of 1.4 million children received 6.0 million intramuscular (IM) vaccines during the study period. The primary analyses evaluated the IM vaccines most commonly administered alone, which included inactivated influenza, hepatitis A, and diphtheria-tetanus-acellular pertussis (DTaP) vaccines. For inactivated influenza and hepatitis A vaccines, local reactions were relatively uncommon, and there was no difference in risk of these events with arm versus thigh injections. The rate of local reactions after DTaP vaccines was higher, and vaccination in the arm was associated with a significantly greater risk of this outcome compared with vaccination in the thigh, both for children 12 to 35 months (relative risk: 1.88 [95% confidence interval: 1.34-2.65]) and 3 to 6 years of age (relative risk: 1.41 [95% confidence interval: 0.84-2.34]), although this difference was not statistically significant in the older age group.

Injection in the thigh is associated with a significantly lower risk of a medically attended local reaction to a DTaP vaccination among children 12 to 35 months of age, supporting current recommendations to administer IM vaccinations in the thigh for children younger than 3 years of age.

4 Reads
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The Advisory Committee on Vaccines of the Spanish Association of Paediatrics upda-tes the immunisation schedule every year, taking into account epidemiological data as wellas evidence on the safety, effectiveness and efficiency of current vaccines, including levelsof recommendation. In our opinion, this is the optimal vaccination calendar for all childrenresident in Spain.Regarding the vaccines included in the official unified immunization schedule, the Committeeemphasizes the administration of the first dose of hepatitis B either at birth or at 2 months oflife; the recommendation of the first dose of MMR and varicella vaccine at the age of 12 months, with the second dose at the age of 2-3 years; DTaP or Tdap vaccine at the age of 6 years, followed by another Tdap booster dose at 11-12 years old; Tdap strategies for pregnant womenand household contacts of the newborn, and immunization against human papillomavirus ingirls aged 11-12 years old with a 2 dose scheme (0, 6 months).The Committee reasserts its recommendation to include vaccination against pneumococcaldisease in the routine immunisation schedule, the same as it is being conducted in WesternEuropean countries.The recently authorised meningococcal B vaccine, currently blocked in Spain, exhibits theprofile of a universal vaccine. The Committe insists on the need of having the vaccine availablein communitary pharmacies.It has also proposed the free availability of varicella vaccines. Their efectiveness and safetyhave been confirmed when they are administred from the second year of life. Vaccinationagainst rotavirus is recommended in all infants. The Committee stresses the need to vaccinatepopulation groups considered at risk against influenza and hepatitis A. © 2013 Asociación Española de Pediatría. Publicado por Elsevier España, S.L.U. Todos los derechos reservados.
    Anales de Pediatría 11/2012; 82(1). DOI:10.1016/j.anpedi.2012.10.002 · 0.83 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Die Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut haben das Ziel, Infektionskrankheiten und damit assoziierte Komplikationen, die für das öffentliche Gesundheitswesen von Bedeutung (,,von öffentlichem Interesse“) sind, durch populationsbezogene Impfprogramme zu verhindern. Darüber hinaus enthalten die STIKO-Empfehlungen Hinweise für Indikationsimpfungen bei besonderer Gefährdungslage und umfassende Informationen zur Durchführung von Nachholimpfungen. Im vorliegenden Beitrag werden die Grundlagen der Impfpraxis sowie die aktuellen Empfehlungen der STIKO mit den wichtigsten Neuerungen beschrieben.
    Monatsschrift Kinderheilkunde 06/2013; 161(12). DOI:10.1007/s00112-013-2919-2 · 0.23 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The administration of injections is a fundamental nursing skill; however, it is not without risk. Children receive numerous vaccines, and pediatric nurses administer the majority of these vaccines via the intramuscular route, and thus must be knowledgeable about safe and evidence-based immunization programs. Nurses may not be aware of the potential consequences associated with poor injection practices, and historically have relied on their basic nursing training or the advice of colleagues as a substitute for newer evidence about how to administer injections today. Evidence-based nursing practice requires pediatric nurses to review current literature to establish best practices and thus improved patient outcomes.
    MCN. The American journal of maternal child nursing 11/2013; DOI:10.1097/NMC.0000000000000009 · 0.90 Impact Factor
Show more


We use cookies to give you the best possible experience on ResearchGate. Read our cookies policy to learn more.